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Huntingtin and Huntingtin-Associated Protein 1
Influence Neuronal Calcium Signaling Mediated
by Inositol-(1,4,5) Triphosphate Receptor Type 1
mechanisms that link the mutation with the disease re-
main controversial (Tobin and Signer, 2000).
A number of Htt binding partners have been identified
in yeast two-hybrid (Y2H) screens with an Htt amino-
terminal fragment (Gusella and MacDonald, 1998; Kalch-
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HAP1 isoform has been identified in humans, and thisVancouver, British Columbia
Canada is most similar to rodent HAP1A (Li et al., 1998b). Associ-
ation of HAP1 with hepatocyte growth factor-regulated
tyrosine kinase substrate (Hrs) (Li et al., 2002), the
p150Glued subunit of dynactin (Engelender et al., 1997;Summary
Li et al., 1998a), and the Rac1 guanine nucleotide ex-
change factor Kalirin-7/Duo (Colomer et al., 1997) hasHuntington’s disease (HD) is caused by polyglutamine
expansion (exp) in huntingtin (Htt). The type 1 inositol been discovered in Y2H screens. Targeted disruption
of the HAP1 gene in mice results in postnatal death and(1,4,5)-triphosphate receptor (InsP3R1) is an intracellu-
lar calcium (Ca2) release channel that plays an impor- depressed feeding behavior, suggesting an important
role of HAP1 in hypothalamic function (Chan et al., 2002).tant role in neuronal function. In a yeast two-hybrid
screen with the InsP3R1 carboxy terminus, we isolated Despite all these data, the role of HAP1 in neuronal
signaling and the pathogenesis of HD remain unclearHtt-associated protein-1A (HAP1A). We show that an
InsP3R1-HAP1A-Htt ternary complex is formed in vitro (Bertaux et al., 1998).
The inositol (1,4,5)-triphosphate receptor (InsP3R) isand in vivo. In planar lipid bilayer reconstitution experi-
ments, InsP3R1 activation by InsP3 is sensitized by an intracellular calcium (Ca2) release channel that plays
an important role in neuronal Ca2 signaling (Berridge,Httexp, but not by normal Htt. Transfection of full-length
Httexp or caspase-resistant Httexp, but not normal Htt, 1998). Three isoforms of InsP3R have been identified
(Furuichi et al., 1994). The type 1 receptor (InsP3R1) isinto medium spiny striatal neurons faciliates Ca2 re-
lease in response to threshold concentrations of the the predominant neuronal isoform. Mice lacking InsP3R1
display severe ataxic behavior (Matsumoto et al., 1996),selective mGluR1/5 agonist 3,5-DHPG. Our findings
identify a novel molecular link between Htt and and mice with a spontaneous mutation in the InsP3R1
gene experience convulsions and ataxia (Street et al.,InsP3R1-mediated neuronal Ca2 signaling and provide
an explanation for the derangement of cytosolic Ca2 1997), suggesting a major role of InsP3R1 in neuronal
function. To identify novel InsP3R1 neuronal bindingsignaling in HD patients and mouse models.
partners, we performed a Y2H screen of a rat brain cDNA
library and isolated neuronal cytoskeleton 4.1N proteinIntroduction
(Maximov et al., 2003) and HAP1A. In the present manu-
script, we describe biochemical and functional interac-Huntington’s disease (HD) has onset usually between
35 and 50 years with chorea and psychiatric distur- tions of InsP3R1 with HAP1A and Htt. The discovered
association of InsP3R1 with HAP1A and Htt providesbances and gradual but inexorable intellectual decline
to death after 15–20 years (Vonsattel and DiFiglia, 1998). additional insight into HAP1 function in the brain and to
our knowledge for the first time links neuronal InsP3R1Neuropathological analysis reveals selective and pro-
gressive neuronal loss in the striatum (Vonsattel et al., function with Htt and HD.
1985), particularly affecting the GABAergic medium
spiny striatal neurons (MSNs). At the molecular level, Results
the cause of HD is a polyglutamine (polyQ) expansion
(exp) in the amino terminus of huntingtin (Htt), a 350 kDa InsP3R1 Binds to HAP1A in the Yeast
ubiquitously expressed cytoplasmic protein (HDCRG, Two-Hybrid System
1993; Nasir et al., 1996). A number of transgenic HD We aimed to identify novel proteins that bind to the
mouse models have been generated, which reproduce carboxy-terminal cytosolic region of the InsP3R1. We
many HD-like features (Menalled and Chesselet, 2002; used the carboxy-terminal region of rat InsP3R1 in the
Rubinsztein, 2002). Despite significant progress, cellular pLexN vector (IC bait, amino acids D2590–A2749) for
Y2H screening of a rat brain cDNA library and isolated
16 positive clones. The clones were rescued and tested*Correspondence: ilya.bezprozvanny@utsouthwestern.edu
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Figure 1. The InsP3R1 Binds HAP1A and Htt in the Yeast Two-Hybrid System and In Vitro
(A) The strength of interaction between each InsP3R1 IC bait and clone 11 (Q273–L599 of rat HAP1A) was determined by a liquid Y2H assay.
The -galactosiadase activity is plotted as a percentage relative to the IC/clone 11 interaction (mean  SE, n  3). On the top, predicted
secondary structure elements within the IC sequence are shown. The predicted minimal fragment of the rat InsP3R1 carboxy terminus
(F2627–G2736) required for association with HAP1A is shaded. The minimal 4.1N binding domain (F2627–R2676) (Maximov et al., 2003) and
minimal PP1 binding region (R2731–A2749) (Tang et al., 2003) are also shown.
(B) The strength of interaction between full-length rat HAP1A, rat HAP1B, and clone 11 with IC10 InsP3R1 bait was determined by liquid Y2H
assay. Data are presented in percentages relative to the observed interaction between clone 11 and IC10 (mean  SE, n  3). The carboxy-
terminal regions unique to HAP1A and HAP1B isoforms are depicted by striped boxes. Also shown are the Htt binding region of HAP1
(L277–K370) (Li et al., 1995, 1998b) and motifs identified in HAP1 by computer analysis.
(C) GST-IC8/IC10 pull-down experiments of HA-HAP1A or HA-HAP1B from COS7 cells extracts.
(D) Lysates from RT1-infected Sf9 cells and COS7 cells overexpressing either HA-HAP1A or HA-HAP1B were mixed for 2 hr and analyzed by
immunoprecipitation with anti-InsP3R1 polyclonal antibodies or corresponding preimmune sera (IP/S).
(E) GST-IC8/IC10 pull-down experiments of Htt-23Q or Htt-82Q from HEK293 cells extracts. COS7 lysate containing overexpressed HA-HAP1A
was added to GST-IC10 pull-down reactions as indicated. The input lanes on (C)–(E) contain 1/50 of the COS7 and HEK293 cell lysates used
in GST pull-down or immunoprecipitation experiments. The precipitated fractions were analyzed by Western blotting with anti-HA monoclonal
antibodies (C and D), or anti-Htt monoclonal antibodies (E).
for their strength of association with the IC bait in a liquid region (F2627–R2676; Figure 1A) and largely comple-
ments the minimal protein phosphatase 1 (PP1) bind-Y2H assay. Three of the 16 isolated clones displayed
especially strong interaction with the IC bait. Two of the ing region (R2731–A2749; Figure 1A) mapped in our pre-
vious studies (Maximov et al., 2003; Tang et al., 2003).strongly interacting clones (clones 7 and 8) corre-
sponded to neuronal cytoskeleton protein 4.1N (Max- Two carboxy-terminal splice variants of HAP1 protein
are expressed in the rodent brain (Li et al., 1995). Cloneimov et al., 2003). The third strongly interacting clone
(clone 11) corresponded to a partial fragment of HAP1A. 11 corresponds to a carboxy-terminal portion of the rat
HAP1A isoform. To address whether both HAP1 iso-To systematically map the HAP1A-interacting domain,
a number of InsP3R1 carboxy-terminal fragments were forms bind InsP3R1 with similar affinity, we cloned full-
length rat HAP1A and HAP1B cDNAs into the Y2H vec-cloned into pLexN vector, and the strength of interaction
with clone 11 (partial HAP1A) was measured in a liquid tors and tested their ability to associate with IC10 bait.
We observed strong interaction between IC10 and eitherY2H assay (Figure 1A). From the obtained results we
concluded that the minimal InsP3R1 region required for full-length HAP1A or clone 11 (Figure 1B). In contrast,
the HAP1B isoform did not display any detectable inter-interaction with HAP1A corresponds to amino acids
F2627–G2736 (Figure 1A, shaded). Thus, the HAP1A- action with IC10. Thus, unique carboxy-terminal sequences
present in HAP1A protein (K578–L599) appear to ro-interacting domain in the InsP3R1 carboxy-terminal re-
gion partially overlaps with the minimal 4.1N-interacting bustly modulate association with the IC10 bait.
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Figure 2. InsP3R1 Is Associated with Htt In Vivo
(A) Rat cerebellar (left) or cortical (right) lysates were used in GST-IC8/IC10 pull-down experiments.
(B) Rat cerebellar (left) or cortical (right) lysates were used in coimmunoprecipitation experiments with anti-InsP3R1 polyclonal antibodies or
corresponding preimmune sera (IP/S). GST-IC8 and GST-IC10 proteins (200 g/ml final concentration) were included in the immunoprecipitation
reactions as indicated. The precipitated fractions on (A) and (B) were analyzed by Western blotting with anti-Htt monoclonal antibodies.
(C and D) Cortical lysates from wild-type (left panel) or HAP1/ (right panel) mice (at postnatal day 3) were used in immunoprecipitation
experiments with the anti-InsP3R1 polyclonal antibodies or with the corresponding preimmune sera (IP/S). The precipitated proteins were
analyzed by Western blotting with the anti-Htt monoclonal antibodies (C) or with the anti-HAP1 monoclonal antibodies (D). An additional 0.5
M KCl wash step was included in the immunoprecipitation protocol as indicated. The input lanes on (A)–(D) contain 1/50 of lysates used in
immunoprecipitation and GST pull-down experiments.
InsP3R1 Binds to HAP1A and Htt In Vitro from HEK293 cell lysates (Figure 1E). Compared to Htt-
82Q, much smaller amounts of Htt-23Q were precipi-To confirm the InsP3R1-HAP1 association, we per-
formed a series of in vitro binding experiments. In the tated by GST-IC10 (Figure 1E). The addition of COS7
cell lysates containing overexpressed HA-HAP1A intofirst experiments, we expressed GST-IC8 and GST-IC10
InsP3R1 carboxy-terminal proteins in E. coli and per- the GST-IC10 pull-down reaction significantly increased
the amount of precipitated Htt-23Q protein (Figure 1E),formed GST pull-downs with extracts from COS7 cells
transiently expressing hemagglutinin-tagged HAP1 pro- but had only a minor effect on the amount of precipitated
Htt-82Q protein (Figure 1E). In control experiments weteins (HA-HAP1A and HA-HAP1B). In agreement with
Y2H data, GST-IC10, but not GST-IC8, specifically asso- detected the expression of endogenous HAP1A protein
in HEK293 cells (data not shown). One explanation ofciated with HA-HAP1A protein (Figure 1C). In further
agreement with Y2H results, GST-IC10 association with our findings is that Htt-82Q bound endogenous HAP1A
with much higher affinity than Htt-23Q. As a result, endoge-HA-HAP1B was much weaker than that with HA-HAP1A
(Figure 1C). nous levels of HAP1A in HEK293 cells were sufficient to
support robust Htt-82Q, but not Htt-23Q, precipitationDo HAP1 proteins bind to full-length InsP3R1? To ad-
dress this, we expressed full-length InsP3R1 (RT1) in Sf9 by GST-IC10. Alternatively, Htt-82Q, but not Htt-23Q,
may be exhibiting strong and direct binding to thecells by baculovirus infection and performed in vitro bind-
ing experiments using lysates from COS7 cells transiently InsP3R1 carboxy terminus, even in the absence of
HAP1A (see Discussion).transfected with HA-HAP1A- or HA-HAP1B-expressing
plasmids. The Sf9 and COS7 cell lysates were incubated
together, precipitated with anti-InsP3R1 polyclonal anti- InsP3R1-HAP1-Htt Association In Vivo
We performed additional GST pull-down experimentsbodies, and blotted with anti-HA monoclonal antibodies.
In agreement with Y2H and GST pull-down experiments, with rat cerebellar and cortical lysates. In agreement
with data using cultured cells, GST-IC10, but not GST-full-length InsP3R1 associated more strongly with HA-
HAP1A than with HA-HAP1B (Figure 1D). IC8, precipitated endogenous Htt from rat brain cerebel-
lar and cortical lysates (Figure 2A). To address whetherSince HAP1 interacts with Htt (Li et al., 1995), we
investigated whether an InsP3R1-HAP1A-Htt ternary InsP3R1 and Htt interacted in vivo, we performed coim-
munoprecipitation experiments with rat brain cerebellarcomplex might be formed. To explore this, we expressed
full-length Htt-23Q or Htt-82Q proteins (Cooper et al., and cortical lysates using anti-InsP3R1 polyclonal anti-
bodies. In agreement with the pull-down data, endoge-1998) in HEK293 cells and performed GST pull-down
experiments. We discovered that GST-IC10 protein, but nous Htt protein is coimmunoprecipitated with the
InsP3R1, even in the presence of GST-IC8 protein, whichnot GST-IC8, efficiently precipitated Htt-82Q proteins
Neuron
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Figure 3. The Httexp Amino Terminus Sensitizes the InsP3R1 to InsP3
(A) Lysates from full-length InsP3R1 (RT1)-infected Sf9 cells were used in pull-down experiments with GST, Htt-N-15Q, and Htt-N-138Q GST-
fusion proteins as indicated. The precipitated fractions were analyzed by Western blotting with anti-InsP3R1 polyclonal antibodies
(B) Effects of GST, Htt-N-15Q, and Htt-N-138Q on activity of recombinant InsP3R1 in planar lipid bilayers at 100 nM InsP3. Each current trace
corresponds to 10 s (2 s for expanded traces) of current recording from the same experiment.
(C) The average InsP3R1 open probability (Po) in the presence of 100 nM InsP3 is calculated for a 5 s window of time and plotted for the
duration of an experiment. Data from the same experiment are shown on (B) and (C). Similar results were obtained in four independent
experiments.
(D) The average InsP3R1 Po plot for the experiment performed in the presence of 2 M InsP3. Similar results were obtained in two independent
experiments. The times of InsP3, GST, Htt-N-15Q, and Htt-N-138Q additions on (C) and (D) are shown above the Po plot.
was added in the reaction (Figure 2B). In contrast to wash did not appreciably decrease the amount of Htt
precipitated by anti-InsP3R1 antibodies from wild-typeGST-IC8, inclusion of GST-IC10 protein into anti-InsP3R1
immunoprecipitation reactions significantly reduced the mouse brain extract (Figure 2C, left panel, fourth lane).
In contrast, the high-salt wash drastically reduced theamounts of precipitated Htt (Figure 2B). These results
are consistent with the formation of an InsP3R1-HAP1- amount of Htt precipitated from HAP1/ brain extracts
(Figure 2C, right panel, fourth lane). From these resultsHtt ternary complex in neurons within rat cerebellum
and cortex regions. Similar results were obtained in ex- we concluded that the presence of HAP1 proteins is
required for the formation of a high-affinity salt-resistantperiments with rat striatal lysates (data not shown).
To determine the requirement of HAP1 for the InsP3R1-Htt association. Western blotting of anti-InsP3R1
immunoprecipitates with HAP1 monoclonal antibodiesInsP3R1-Htt association, we studied brain extracts from
mice with targeted disruption of HAP1 (Chan et al., 2002). confirmed the preferential binding of InsP3R1 to the
HAP1A isoform (Figure 2D, left panel) and the absenceIn these experiments, brain extracts from HAP1/
mouse pups and wild-type control littermates were used of both HAP1 isoforms in HAP1/ samples (Figure 2D,
right panel). The binding of InsP3R1 to HAP1 was notin immunoprecipitaion experiments with anti-InsP3R1
polyclonal antibodies. The precipitated fractions were significantly affected by the 0.5 M KCl wash (Figure 2D,
left panel).blotted with anti-Htt monoclonal antibodies. In agree-
ment with the rat brain coimmunoprecipitation results,
we found that anti-InsP3R1 polyclonal antibodies specif- Httexp, but Not Normal Htt, Activates InsP3R1
In Vitroically precipitated Htt from wild-type mouse cortical ly-
sates (Figure 2C, left panel, third lane). Slightly reduced The HAP1 binding site and the site of polyQ expansion
are localized to the most amino-terminal region of Httamounts of Htt protein were precipitated by anti-InsP3R1
polyclonal antibodies from HAP1/ cortical lysates (Fig- protein (Li et al., 1995). We expressed amino-terminal
fragments (Htt-N, amino acids 1–158) of Htt-15Q andure 2C, right panel, third lane). To investigate preferen-
tially strong protein-protein interactions, an additional Htt-138Q as GST-fusion proteins and confirmed associ-
ation of Htt-N-15Q and Htt-N-138Q with HA-HAP1A0.5 M KCl washing step was employed. The 0.5 M KCl
InsP3R1-HAP1A-Htt Functional Complex
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(data not shown). We further demonstrated that bacteri-
ally expressed Htt-N-15Q and Htt-N-138Q proteins spe-
cifically precipitated recombinant full-length InsP3R1
from Sf9 cell lysates (Figure 3A). Since Sf9 lysates do
not contain any HAP1 (data not shown), this Htt-N inter-
action with full-length InsP3R1 appears to be direct. Our
GST-IC10 pull-down experiments (Figure 1E) and immu-
noprecipitation experiments from HAP1/ cortical ly-
sates (Figure 2C) also support the existence of a direct
Htt-InsP3R1 interaction. InsP3R1 associated with Htt-
N-138Q more strongly than with Htt-N-15Q (Figure 3A),
although this difference was less dramatic than the dif-
ference between Htt-23Q and Htt-82Q in GST-IC10 pull-
down experiments (Figure 1E).
What are the functional consequences of InsP3R1 as-
sociation with HAP1 and Htt? To address this, we ex-
pressed InsP3R1 in Sf9 cells and reconstituted recombi-
nant InsP3R1 into planar lipid bilayers as previously
described (Tang et al., 2003; Tu et al., 2002). Addition
of 100 nM InsP3 to the cis (cytosolic) chamber induced
low levels of InsP3R1 activity (Figure 3B, second trace,
and Figure 3C). Further addition of GST protein or repeti-
tive additions of Htt-N-15Q protein directly to the bilayer
had no effect on InsP3R1 activity (Figure 3B, traces 3–5,
and Figure 3C). In contrast, addition of Htt-N-138Q pro-
tein to the same bilayer resulted in facilitation of InsP3R1
activity (Figure 3B, trace 6, and Figure 3C). On average,
InsP3R1 open probability was equal to 0.020  0.008
(n 16) in the presence of 100 nM InsP3, 0.02 0.01 (n
6) after addition of Htt-N-15Q, and 0.19  0.05 (n  4)
after addition of Htt-N-138Q. The facilitation of InsP3R1
activity by Htt-N-138Q was most pronounced at low InsP3
concentrations. When InsP3R1 was activated by 2 M
InsP3, additions of GST, Htt-N-15Q, and Htt-N-138Q pro-
teins did not have a significant effect on InsP3R1 open
Figure 4. The Htt Amino Terminus Facilitates InsP3R1 Activity in theprobability (Figure 3D). From these results, we con-
Presence of HAP1Acluded that Htt-N-138Q, but not Htt-N-15Q, sensitizes
(A) Effects of HAP1A, Htt-N-15Q, and Htt-N-138Q on activity ofInsP3R1 to activation by submaximal doses of InsP3. recombinant InsP3R1 in planar lipid bilayers in the presence of 100To evaluate the role of HAP1 in InsP3R1 activation by nM InsP3. Each current trace corresponds to 10 s (2 s for expanded
Htt, we expressed and purified full-length HAP1A as a traces) of current recording from the same experiment.
GST-fusion protein. Addition of HAP1A to the bilayer (B) The average InsP3R1 open probability (Po) in the presence of 100
nM InsP3 is calculated for a 5 s window of time and plotted for thehad no effect on the activity of InsP3R1 in the presence
duration of an experiment. The times of InsP3, HAP1A, Htt-N-15Q,of 100 nM InsP3 (Figure 4A, third trace, and Figure 4B).
and Htt-N-138Q additions to the bilayer are shown above the PoIn contrast to previous experiments (Figures 3B and
plot. Data from the same experiment are shown on (A) and (B).3C), addition of Htt-N-15Q to the bilayer pre-exposed
Similar results were obtained in two independent experiments or in
to HAP1A facilitated InsP3R1 activity (Figure 4A, fourth experiments when HAP1A and Htt-N-15Q (n 4) or HAP1A and Htt-
trace, and Figure 4B). The following addition of Htt- N-138Q (n  4) were premixed.
N-138Q to the same membrane had an additional po-
tentiating effect (Figure 4A, trace 5, and Figure 4B). Simi-
baculoviruses expressing full-length Htt-23Q and Htt-lar results were obtained in the experiments when
82Q and used them in coinfection experiments with RT1HAP1A was premixed with Htt-N-15Q or Htt-N-138Q
baculovirus encoding InsP3R1. In immunoprecipitationprior to addition to the bilayer (data not shown). On
experiments we found that InsP3R1 and Htt-23Q/82Qaverage, InsP3R1 open probability was equal to 0.020
formed a complex when coexpressed in Sf9 cells (Figure0.008 (n  16) in the presence of 100 nM InsP3, 0.14 
5A), which do not contain any detectable HAP1. As such,0.04 (n  5) after addition of HAP1A  Htt-N-15Q, and
interaction of the InsP3R1 with Htt23Q/82Q in Sf9 cells0.26  0.11 (n  5) after addition of HAP1A  Htt-
appears direct, consistent with our earlier findings. Simi-N-138Q. From these in vitro functional experiments and
lar to pull-down data gathered with the GST-Htt-N pro-our biochemical data, we concluded that HAP1A facili-
tein (Figure 3A), binding of Htt to full-length InsP3R1 wastates activation of InsP3R1 by Htt, most likely by promot-
only modestly modulated by polyQ expansion.ing Htt association with InsP3R1 carboxy terminus (Fig-
Microsomes prepared from Sf9 cells coinfected withure 1E).
RT1 and Htt-23Q or Htt-82Q baculoviruses were fusedSince amino-terminal Htt fragments were used in bi-
to planar lipid bilayers. No channel activity was observedlayer experiments shown above, we determined the ef-
fect of full-length Htt on InsP3R1 activity. We generated in control experimental conditions (Figures 5B and 5D,
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Figure 5. Full-Length Httexp Sensitizes InsP3R1
to Activation by InsP3
(A) Microsomes from Sf9 cells coinfected with
RT1 and Htt-23Q or Htt-82Q baculoviruses
were solubilzed in 1% CHAPS, precipitated
with anti-InsP3R1 polyclonal antibodies, and
blotted with the anti-Htt monoclonal antibod-
ies. The input lanes contain 1/10 of lysates
used in the immunoprecipitation experi-
ments.
(B) Activity of InsP3R1 coexpressed in Sf9
cells with Htt-23Q and reconstituted into pla-
nar lipid bilayers. Responses to application
of 100 nM InsP3 and 2 M InsP3 are shown.
Each current trace corresponds to 10 s (2 s
for expanded traces) of current recording
from the same experiment.
(C) The average InsP3R1 open probability (Po)
was calculated for a 5 s window of time and
plotted for the duration of an experiment. The
times of 100 nM and 2 M InsP3 additions to
the bilayer are shown above the Po plot. Data
from the same experiment are shown on (B)
and (C). Similar results were obtained in four
independent experiments.
(D and E) Same as (B) and (C) for InsP3R1
coexpressed in Sf9 cells with Htt-82Q. Similar
results were obtained in six independent ex-
periments.
first trace). Addition of 100 nM InsP3 induced only low ments (data not shown), confirming their identity as
MSNs (Chesselet et al., 1993; Mao and Wang, 2001). Welevels of channel activity in InsP3R1 coexpressed with
transfected MSNs at 20 days in vitro (DIV) with full-lengthHtt-23Q (Figure 5B, second trace, and Figure 5C), but
Htt-23Q, Htt-82Q, or Htt-138Q expression plasmids. Toresulted in dramatic activation of InsP3R1 coexpressed
identify transfected cells, the Htt plasmids were cotrans-with Htt-82Q (Figure 5D, second trace, and Figure 5E).
fected with enhanced green fluorescent protein (EGFP)-Elevation of InsP3 concentration to 2M increased activ-
expressing plasmid. During transfections, the Htt:EGFPity of InsP3R1 coexpressed with Htt-23Q (Figure 5B, third
plasmid ratio was kept at 3:1 to ensure that every GFP-trace, and Figure 5C) and had no additional effect on
positive cell was transfected with Htt-expressing plas-activity of InsP3R1 coexpressed with Htt-82Q (Figure 5D,
mid. In control experiments, MSNs were transfectedthird trace, and Figure 5E). From these experiments we
with the EGFP plasmid alone. Only GFP-positive cellsconcluded that sensitivity of InsP3R1 to activation by
were compared in our analysis of different Htt con-InsP3 is increased by formation of a complex with Htt-
structs.82Q full-length protein, but not with Htt-23Q full-length
In contrast to striatal interneurons, MSNs abundantlyprotein.
express phospholipase C (PLC)-linked mGluR1/5 recep-
tors (Mao and Wang, 2001, 2002; Tallaksen-Greene et
Httexp Activates InsP3R1 in Cultured MSNs al., 1998). To stimulate InsP3R1-mediated Ca2 release,
Striatal MSN neurons are the most selectively and se- we challenged Fura-2-loaded MSN neurons with 10 M
verely affected in HD (Vonsattel et al., 1985). To test 3,5-dihydroxyphenylglycine (DHPG), a specific mGluR1/5
the in vivo functional effects of Httexp on InsP3R1, we receptor agonist (Mao and Wang, 2002; Schoepp et al.,
established primary MSN cultures from E18 embryonic 1999). To exclude the contribution of N-methyl-D-aspar-
rats (Mao and Wang, 2001). Over 90% of striatal neurons tate receptors (NMDAR) and L-type Ca2 channels to
are projection GABAergic MSNs (Gerfen, 1992). A large the observed Ca2 signals and to simplify the analysis,
fraction of cells in our cultures (90%) were strongly the imaging experiments were performed in Ca2-free
media containing 100 M EGTA (see Experimental Pro-positive for GAD65 marker in immunostaining experi-
InsP3R1-HAP1A-Htt Functional Complex
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Figure 6. Effects of Httexp on DHPG-Induced Ca2 Release in Transfected Medium Spiny Neurons
Representative images showing Fura-2 340/380 ratios in transfected rat medium spiny neurons (MSNs). The pseudocolor calibration scale
for 340/380 ratios is shown on the right. Ratio recordings are shown for 10 M DHPG-induced Ca2 transients in MSN neurons transfected
with EGFP (first row), EGFP  Htt-23Q (second row), EGFP  Htt-82Q (third row), and EGFP  Htt-138Q (fourth row). The recordings were
performed in Ca2-free ACSF containing 100 M EGTA. GFP images (1st column) were captured before Ca2 imaging to identify transfected
cells (arrowheads). 340/380 ratio images are shown for MSN neurons 1 min before (2nd column), and 8 s, 30 s, 1 min, 2 min, and 3 min after
application of 10 M DHPG as indicated. The GFP-negative cell that responds to 10 M DHPG in the third row (triangle arrow) is interpreted
to correspond to a neuron transfected with Htt-82Q plasmid alone. We used Htt:EGFP plasmids at a 3:1 ratio during transfections, which
probably resulted in the expression of Htt in some GFP-negative MSNs. Only GFP-positive MSNs were considered for quantitative analyses
shown on Fig 7.
cedures for details). The local Ca2 concentration in 0.015 (n  21) for EGFP  Htt-138Q (Figures 7C, 7E,
7G, and 7I). The basal Ca2 levels were significantly (p	these experiments is estimated from the ratio of Fura-2
signals at 340 nm and 380 nm excitation wavelengths 0.01, unpaired t test) higher in Htt-transfected MSNs as
compared to control MSNs. These results are in agree-as shown by pseudocolor images. Representative data
with EGFP, EGFP  Htt-23Q, EGFP  Htt-82Q, and ment with elevated basal Ca2 levels observed in hippo-
campal neurons from YAC46 transgenic HD mice (Hodg-EGFP  Htt-138Q transfected MSN neurons are shown
on Figure 6. The transfected cells were identified by son et al., 1999).
Ten micromolar DHPG corresponds to a thresholdGFP imaging (Figure 6, first column, arrows) prior to
collecting quantitative Fura-2 340/380 ratio data. We concentration for mGluR1/5 receptor activation in MSN
neurons, and only a small response to DHPG applicationnoticed that prior to application of DHPG, the basal
Ca2 levels were slightly elevated in Htt-transfected cells at this concentration was observed in control MSNs
transfected with EGFP plasmid alone (Figure 6, first row,when compared to control cells (Figure 6, second col-
umn). On average, the basal 340/380 ratio was equal to and Figures 7A and 7B) and in MSN neurons transfected
with Htt-23Q plasmid (Figure 6, second row, and Figures0.43 0.02 (n 14) for EGFP-transfected cells (Figures
7A and 7I), 0.51  0.02 (n  18) for EGFP  Htt-23Q, 7C and 7D). In contrast, significant response to 10 M
DHPG was observed in MSNs transfected with Htt-82Q0.55  0.02 (n  29) for EGFP  Htt-82Q, and 0.54 
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Figure 7. Httexp Facilitates DHPG-Induced
Ca2 Release in Medium Spiny Neurons
Basal and peak 340/380 ratios are shown for
individual MSN neurons transfected with (A),
EGFP, (C), EGFPHtt-23Q, (E), EGFPHtt-
82Q, (G), EGFPHtt-138Q. The experiments
were performed as described in Figure 6.
Only GFP-positive MSNs were considered for
quantitative analysis for each group of cells.
The basal ratios were determined 1 min prior
to DHPG application (1 min). The peak ra-
tios were measured from maximal signals ob-
served within 30 s after DHPG application.
340/380 ratio traces for representative cells
(marked *) are shown in (B), (D), (F), and (H).
Time of DHPG application is shown. Similar
results were obtained in four independent
transfections. (I) Summary of MSN Ca2 im-
aging experiments with Htt and Htt(R) con-
structs. Average basal and DHPG-evoked
peak 340/380 ratios from four independent
transfections are shown as mean SEM (n
number of cells). These averages represent
the data shown in this figure in addition to
data from other experiments. The peak ratios
in MSNs transfected with EGFP  Htt-82Q,
EGFP  Htt-138Q, or EGFP  Htt(R)-138Q
are significantly (***p 	 0.001, paired t test)
higher than the basal ratios in the same cells.
plasmid (Figure 6, third row, and Figures 7E and 7F). transfected cells to 10 M DHPG. We discovered that
Htt(R)-138Q, but not Htt(R)-15Q, significantly potenti-Even stronger response to this agonist was observed
in MSNs transfected with Htt-138Q plasmid (Figure 6, ated DHPG-induced Ca2 release in MSNs (Figure 7I).
Importantly, the potentiating effects of caspase-resis-fourth row, and Figures 7G and 7H). Paired t test analysis
revealed that peak 340/380 ratios were significantly (p	 tant Htt(R)-138Q and the cleavable form of Htt-138Q
were similar (Figure 7I). From these results, we con-0.001) higher than basal 340/380 ratios in Htt-82Q and
Htt-138Q transfected neurons, but not in Htt-23Q and cluded that Httexp does not require proteolytic cleavage
by caspases 3 and 6 to have potentiating effects onEGFP-only transfected neurons (Figure 7I). Thus, we
concluded that overexpression of full-length Httexp sensi- InsP3R1-mediated Ca2 release in MSN neurons.
tizes InsP3R1 to InsP3 in MSN neurons. The effects of
Httexp on InsP3R1 function were most pronounced at Discussion
threshold levels of stimulation, as control, Htt-, and
Httexp-transfected MSN neurons responded in a similar Huntington’s Disease and Abnormal Ca2 Signaling
Programmed neuronal death (apoptosis) underlies themanner to 500 M DHPG (data not shown).
Htt is a substrate for cleavage by caspases, and Htt symptoms of many neurodegenerative disorders, in-
cluding Alzheimer’s, Parkinson’s, and Huntington’s dis-proteolysis may be an early step in the pathogenesis of
HD (Wellington et al., 2000, 2002). Removal of caspase ease (Mattson, 2000). Ca2 plays an important role in
neuronal signaling (Berridge, 1998), and perturbed Ca23 and 6 cleavage sites in the Htt quintuple caspase-
resistant mutants [Htt(R)] reduces Httexp proteolysis and homeostasis is one of the key steps during initiation of
the apoptotic program in affected neurons (Mattson andtoxicity in apoptotically stressed neurons (Wellington et
al., 2000). Does sensitization of InsP3R1 by Httexp depend Chan, 2001). Abnormalities in ER-mediated Ca2 signal-
ing due to a mutation of presenilin 1 have been linkedon prior cleavage by caspases? To answer this question,
we cotransfected MSN neurons with EGFP  Htt(R)- to the development of Alzheimer’s disease (Mattson and
Chan, 2001). Several lines of experimental evidence15Q or EGFP  Htt(R)-138Q and analyzed responses of
InsP3R1-HAP1A-Htt Functional Complex
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point to a connection between HD and aberrant neuronal
Ca2 signaling. Abnormally high cytosolic Ca2 levels
were detected in CA1 pyramidal neurons from the YAC46
HD mouse model (Hodgson et al., 1999). The lymphoblast
mitochondria of HD human patients and brain mitochon-
dria from the YAC72 HD mouse model display abnormal
Ca2 homeostasis (Panov et al., 2002). The derangement
in Ca2 signaling occurs early (Panov et al., 2002) and
can therefore be invoked as an initiating event in the
pathogenesis of HD, followed by activation of caspases
in response to high Ca2 levels (Juin et al., 1998; Zeron et
al., 2002). In addition to promoting apoptosis, increased
caspase activity would be expected to catalyze Httexp
proteolysis (Wellington et al., 2002), resulting in the gen-
eration of toxic amino-terminal Httexp fragments (Hackam
et al., 1998). Abnormally high Ca2 levels would also
be expected to promote Httexp proteolysis via calpain-
dependent mechanisms (Goffredo et al., 2002; Kim et
al., 2001).
What are the molecular mechanisms linking the Httexp
mutation with increased Ca2 levels in affected neurons?
Httexp alters mitochondrial Ca2 homeostasis by directly
interacting with the mitochondrial membrane (Panov et
al., 2002). While this interaction likely contributes to mi-
tochondrial dysfunction, it remains unclear how intracel-
lular Ca2 is affected by Httexp at the mitochondria. An
alternative molecular mechanism has been suggested
by the recent description of a Htt-PSD95-NMDAR com-
plex (Sun et al., 2001) and the ability of Httexp to potentiate
NMDAR function (Chen et al., 1999; Sun et al., 2001;
Zeron et al., 2002). In addition to influx via NMDAR and
voltage-gated Ca2 channels, neuronal Ca2 is also
largely influenced by release from intracellular stores in
the endoplasmic reticulum (ER) upon activation of class
1 metabotropic glutamate receptors (mGluR1/5) (Pin
and Duvoisin, 1995). The alterations in ER enzymes that
have been observed in HD brains (Cross et al., 1985)
might be caused by abnormal Ca2 release from the
Figure 8. Proposed Mechanism Linking Httexp to Increased InsP3R1- ER (Korkotian et al., 1999). Here, we describe a novel
and NMDAR-Mediated Neuronal Ca2 Signaling in Medium Spiny mechanism linking Httexp to InsP3R1-mediated Ca2 re-
Neurons of HD Patients lease from the ER in striatal MSNs.
Glutamate released from corticostriatal projection neurons stimu-
lates NR1A/NR2B NMDAR and mGluR5 receptors on striatal medium
InsP3R1-HAP1A-Htt Functional Complexspiny neurons (MSNs).
We have identified a protein complex that contains(A) In normal MSNs, NMDAR activation triggers Ca2 influx from
InsP3R1, Htt, and HAP1. This complex was discoveredextracellular sources. Activation of mGluR5 stimulates phospholi-
pase C (PLC) via a heterotrimeric G protein (G) pathway to generate through the identification of HAP1A as a binding partner
diacylglycerol (DAG) and inositol triphosphate (InsP3) second mes- of the InsP3R1 cytosolic carboxy-terminal tail in the Y2H
sengers. Activation of mGluR5 cooperates with NMDAR activation screen (Figures 1A and 1B). In biochemical experiments,
largely through the actions of DAG, which activates PKC. The InsP3 we found that Htt directly interacts with the InsP3R1generated downstream of mGluR5 does not trigger robust Ca2
cytosolic carboxy-terminal tail and that binding to thisrelease from the endoplasmic reticulum (ER) in response to low
limited region of InsP3R1 was highly dependent on bothlevels of glutamate, as InsP3R1 sensitivity to InsP3 is low. The associ-
ation of Htt with the cytosolic carboxy-terminal tail of the InsP3R1 the presence of HAP1A and polyQ expansion within Htt
is weak and with the PSD95-NR1A/NR2B is strong. In this schematic, (Figure 1E). Htt also binds to full-length InsP3R1, but this
only the interaction of Htt with the InsP3R1 carboxy-terminal tail is interaction is not strongly modulated by polyQ expan-
represented. This interaction appears to be stabilized by the pres-
sion (Figures 3A and 5A) or the presence of HAP1Aence of HAP1A (labeled as HAP1) in normal MSNs.
(Figures 2C, 3A, and 5A).(B) In MSNs of Huntington’s disease (HD) patients, Httexp perturbs
The effects of Htt and HAP1A on InsP3R1 functionCa2 signaling via two synergistic mechanisms. Httexp enhances
NMDAR function, possibly through decreased interaction with the are largely consistent with our biochemical analysis. In
PSD95-NR1A/NR2B complex. In addition, Httexp strongly binds to
InsP3R1 carboxy terminus and sensitizes the InsP3R1 to activation
by InsP3. As a result, low levels of glutamate released from cortico-
striatal projection neurons lead to supranormal Ca2 influx via Ca2-dependent downstream pathways such as increased caspase
NMDAR and Ca2 release via the InsP3R1. The net result is elevated and calpain activity, increased Htt proteolysis, activation of the apo-
intracellular Ca2 levels in MSNs that eventually trigger pathogenic ptotic program, and MSN degeneration.
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pLexN vector (IC bait). The yeast two-hybrid screen of a rat brainplanar lipid bilayer experiments, the Httexp amino termi-
(P8-P9) cDNA library (kind gift of Dr. T. Su¨dhof) with the IC baitnus or full-length Httexp, but not wild-type Htt, greatly
and liquid yeast two-hybrid assays were performed as previouslyfacilitated InsP3R1 activity at 100 nM InsP3 (Figures 3B, described (Maximov et al., 2003).
3C, 5D, and 5E). However, the amino terminus of wild-
type Htt facilitated InsP3R1 activity in the presence of Plasmids
HAP1A (Figures 4A and 4B). Thus, InsP3R1 is sensitized The following rat InsP3R1 (Mignery et al., 1990) baits in pLexN vec-
to InsP3 in conditions when Htt binds to the InsP3R1 tor were generated by PCR (listed by encoded amino acid and
residue numbers): IC D2590–A2749, IC_G2736X D2590–G2736,carboxy terminus (Httexp or Htt with HAP1A), but not in
IC3  R2676–A2749, IC4  Q2714–A2749, IC5  D2590–Q2714,conditions when Htt does not bind to InsP3R1 carboxy
IC6 D2590–R2676, IC7 D2590–L2646, IC8 D2590–F2627, IC9terminus (Htt alone). From these results we concluded
L2646–A2749, IC10  F2627–A2749. The InsP3R1 expression con-that association of Httexp or Htt-HAP1A with InsP3R1 car- structs in pGEX-KG are GST-IC8  D2590–F2627 and GST-IC10 
boxy terminus sensitizes InsP3R1 to activation by InsP3. F2627–A2749. The full-length clones of rat HAP1A and HAP1B (Li
et al., 1995) were amplified by RT-PCR from rat brain mRNA and
cloned into the pVp16-3 yeast two-hybrid prey vector, pCMV-HASensitization of InsP3R1 and NMDAR by Httexp
mammalian expression vector, and pGEX-KG bacterial expressionand Huntington’s Disease
vector. Full-length Htt plasmids Htt-23Q (HD-FL-23Q) and Htt-82QThe molecular and cellular basis for selective vulnerabil-
(HD-FL-82Q) in pRc/CMV expression vector were kindly providedity of MSNs in HD remains elusive. One proposed mech-
by Dr. Christopher A Ross (Cooper et al., 1998). The full-length Htt-
anism is centered on the finding that MSNs primarily 15Q and Htt-138Q plasmids (Wellington et al., 2000) were cloned
express the NR1A/NR2B subtype of NMDAR (Kuppen- into the pCI expression vector (Promega). The caspase 3 and 6
bender et al., 1999; Landwehrmeyer et al., 1995; Zeron resistant Htt quintuple mutant plasmids Htt(R)-15Q and Htt(R)-138Q
in pRc/CMV vector have been previously described (Wellington etet al., 2002). Importantly, Httexp appears to selectively
al., 2000). The Htt-N expression constructs in pGEX-KG are Htt-enhance the activity of NR1A/NR2B channels, relative
N-15Q/138Q  M1–K158 of human Htt.to other NMDAR subtypes, suggesting that increased
NMDAR function might be specifically occurring in
GST Pull-Down AssaysMSNs of HD patients (Chen et al., 1999; Sun et al., 2001;
GST-IC8 and GST-IC10 proteins were expressed in the BL21 E. coli
Zeron et al., 2001). Our results suggest another possible strain and purified on glutathione-agarose beads. HA-HAP1A and
explanation for selectivity in HD involving the enrichment HA-HAP1B were expressed in COS7 cells by DEAE-dextran trans-
of mGluR5, a member of the group I mGluRs, in MSNs fection (Sambrook et al., 1989). Htt-23/82Q proteins were expressed
in HEK293 cells by calcium-phosphate transfection (Sambrook et(Kerner et al., 1997; Mao and Wang, 2001, 2002; Tallak-
al., 1989). 48 hr after transfection, COS7 or HEK293 cells were col-sen-Greene et al., 1998). Stimulation of group I mGluR
lected with ice-cold PBS and solubilized for 30 min at 4
C in extrac-in MSNs leads to the generation of InsP3 and release of
tion buffer A (1% CHAPS, 137 mM NaCl, 2.7 mM KCl, 4.3 mMCa2 via InsP3R1 (Mao and Wang, 2002). In addition, Na2HPO4, 1.4 mM KH2PO4 [pH 7.2], 5 mM EDTA, 5 mM EGTA, andstimulation of group I mGluR is known to potentiate protease inhibitors). Extracts were clarified by centrifugation for 20
NMDAR activity in neurons, most likely via a PKC- min at 100,000  g and incubated for 1 hr at 4
C with GST-IC8
dependent pathway (Calabresi et al., 1999; Pisani et al., or GST-IC10 proteins. Beads were washed three times with the
extraction buffer A. Attached proteins were analyzed by Western2001; Skeberdis et al., 2001).
blotting with anti-Htt or anti-HA monoclonal antibodies.In striatal MSNs, the presence of full-length Httexp sen-
sitizes Ca2 release in response to subthreshold con-
In Vitro Binding Assaycentrations of the mGluR1/5 agonist DHPG (Figures 6
Full-length rat InsP3R1 (RT1)-encoding baculoviruses were pre-and 7). We propose that sensitizing influences of Httexp
viously described (Tu et al., 2002). Full-length Htt plasmids Htt-23Q
on InsP3R1 and the NR1A/NR2B subtype of NMDAR and Htt-82Q (Cooper et al., 1998) were subcloned into pFastBac1
(Chen et al., 1999; Sun et al., 2001; Zeron et al., 2001) vector (Invitrogen), and Htt-23Q/82Q baculoviruses were generated
have a synergistic effect on glutamate-induced Ca2 using Bac-to-Bac system (Invitrogen). The Spodoptera frugiperda
(Sf9) cells (100 ml) were infected with RT1 viruses or coinfected withsignals in MSNs of HD individuals (Figure 8). In MSNs
RT1:Htt-23Q/82Q viral mixtures (3:1) and collected by centrifugationof HD patients, the activation of both mGluR5 and
72 hr postinfection. The RT1-infected cells were solubilized in ex-NMDAR by low concentrations of glutamate released by
traction buffer A, cleared by centrifugation (100,000 g), and mixedcorticostriatal projection neurons leads to supranormal
with an equal volume of HA-HAP1A or HA-HAP1B-expressing COS7
Ca2 signals (Figure 8B) when compared to normal lystates prepared as described above for 2 hr at 4
C. The mixture
MSNs (Figure 8A), resulting in neuronal dysfunction and was precipitated with anti-InsP3R1 polyclonal antibody (T443)
apoptosis. Overall, our findings provide support for the attached to protein A-Sepharose beads and analyzed by Western
blotting with anti-HA monoclonal antibodies. The cells coinfectedhypothesis that perturbation of neuronal Ca2 signaling
with RT1 and Htt-23Q/82Q baculoviruses were used to prepare mi-mediated by NMDAR and InsP3R1 may be a primary
crosomes for bilayer experiments as previously described (Tu et al.,cause of MSN selectivity in HD. In our model, the toxic
2002). Obtained microsomes were solubilized in extraction buffer“gain of Httexp function” (Tobin and Signer, 2000) corre-
A, cleared by centrifugation (100,000  g in TL-100), used in immu-
sponds to the polyQ-dependent ability of Httexp to sensi- noprecipitation experiments with anti-InsP3R1 polyclonal antibod-
tize NMDAR and InsP3R1-mediated Ca2 signals in MSN ies, and analyzed by Western blotting with anti-Htt monoclonal anti-
neurons (Figure 8B). In addition, our model points to bodies.
mGluR5 as potential target for pharmacological treat-
Brain Pull-Downs and Immunoprecipitationsment of HD.
Rat and mouse brain tissues were isolated, homogenized, and solu-
bilized for 1.5 hr at 4
C in extraction buffer A. The lysate was clarifiedExperimental Procedures
by 20 min centrifugation at 100,000  g and utilized in pull-down
experiments with GST-IC8 and GST-IC10 proteins or in the immuno-Yeast Two-Hybrid Methods
precipitation experiments with anti-InsP3R1 polyclonal antibodiesThe carboxy-terminal region of rat InsP3R1 (Mignery et al., 1990)
(amino acids D2590–A2749) was amplified by PCR and cloned into (T443) performed as described above. GST-IC8 and GST-IC10 pro-
InsP3R1-HAP1A-Htt Functional Complex
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